GENETIC TECHNOLOGIES LIMITEDGENETIC TECHNOLOGIES LIMITEDGENETIC TECHNOLOGIES LIMITED

GENETIC TECHNOLOGIES LIMITED

No trades
See on Supercharts
Market capitalization
‪20.20 M‬AUD
−0.125AUD
‪−11.75 M‬AUD
‪8.69 M‬AUD
‪115.42 M‬
Beta (1Y)
2.27

About GENETIC TECHNOLOGIES LIMITED

CEO
Simon Morriss
Headquarters
Fitzroy
Employees (FY)
60
Founded
1987
ISIN
AU000000GTG7
FIGI
BBG000MGW2P2
Genetic Technologies Ltd. operates as a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. It operates through EasyDNA, AffinityDNA and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment focuses on AffinityDNA branded test sales and expenses.The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GTG is 0.140 AUD — it has decreased by 20.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange GENETIC TECHNOLOGIES LIMITED stocks are traded under the ticker GTG.
GENETIC TECHNOLOGIES LIMITED is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
GTG stock is 34.62% volatile and has beta coefficient of 2.27. Check out the list of the most volatile stocks — is GENETIC TECHNOLOGIES LIMITED there?
GENETIC TECHNOLOGIES LIMITED revenue for the last quarter amounts to ‪4.15 M‬ AUD despite the estimated figure of ‪7.30 M‬ AUD. In the next quarter revenue is expected to reach ‪4.20 M‬ AUD.
Yes, you can track GENETIC TECHNOLOGIES LIMITED financials in yearly and quarterly reports right on TradingView.
GTG stock has fallen by 15.15% compared to the previous week, the month change is a 12.00% rise, over the last year GENETIC TECHNOLOGIES LIMITED has showed a 53.33% decrease.
GTG net income for the last quarter is ‪−6.42 M‬ AUD, while the quarter before that showed ‪−6.29 M‬ AUD of net income which accounts for −2.04% change. Track more GENETIC TECHNOLOGIES LIMITED financial stats to get the full picture.
Today GENETIC TECHNOLOGIES LIMITED has the market capitalization of ‪20.20 M‬, it has decreased by 3.57% over the last week.
No, GTG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GTG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENETIC TECHNOLOGIES LIMITED stock right from TradingView charts — choose your broker and connect to your account.
GTG reached its all-time high on Aug 15, 1990 with the price of 4630.610 AUD, and its all-time low was 0.095 AUD and was reached on Jan 23, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 60.00 employees. See our rating of the largest employees — is GENETIC TECHNOLOGIES LIMITED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENETIC TECHNOLOGIES LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENETIC TECHNOLOGIES LIMITED stock shows the sell signal. See more of GENETIC TECHNOLOGIES LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENETIC TECHNOLOGIES LIMITED EBITDA is ‪−9.12 M‬ AUD, and current EBITDA margin is −127.66%. See more stats in GENETIC TECHNOLOGIES LIMITED financial statements.